KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Trends Analyst Outlook Journalist POV

47 hedge funds and large institutions have $42.5M invested in KalVista Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$453K
2
+$351K
3
+$140K
4
AHB
Abner Herrman & Brock
New Jersey
+$113K
5
OPPM
Opus Point Partners Management
New York
+$63K

Top Sellers

1
-$576K
2
-$408K
3
-$342K
4
Goldman Sachs
Goldman Sachs
New York
-$177K
5
SFM
Sphera Funds Management
Israel
-$145K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$64K
27
$63K
28
$58K
29
$49K
30
$44K
31
$41K
32
$35K
33
$28K
34
$26K
35
$25K
36
$22K
37
$18K
38
$13K
39
$11K
40
$10.2K
41
$3K
42
$3K
43
$3K
44
$1K
45
$1K
46
$4
47
–
48
–
49
–
1
2